DENTSPLY SIRONA (NASDAQ:XRAY) had its target price hoisted by UBS Group from $42.00 to $53.00 in a research report report published on Tuesday morning, www.analystratings.com reports. UBS Group currently has a neutral rating on the medical instruments supplier’s stock.
Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of DENTSPLY SIRONA from a hold rating to a buy rating and set a $55.00 price target for the company in a research report on Saturday, March 9th. William Blair raised shares of DENTSPLY SIRONA from a market perform rating to an outperform rating in a research report on Friday, March 1st. Robert W. Baird raised their price target on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the company a neutral rating in a research report on Monday, March 4th. HC Wainwright reissued a neutral rating and set a $49.00 price target (up previously from $40.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 4th. Finally, Barclays set a $49.00 price target on shares of DENTSPLY SIRONA and gave the company a hold rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of Hold and an average target price of $51.33.
XRAY stock opened at $49.19 on Tuesday. DENTSPLY SIRONA has a 52-week low of $33.93 and a 52-week high of $57.83. The company has a market cap of $10.97 billion, a PE ratio of 24.47, a price-to-earnings-growth ratio of 2.56 and a beta of 1.08. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Friday, March 29th will be given a $0.087 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date is Thursday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 17.41%.
A number of large investors have recently bought and sold shares of the business. Norges Bank bought a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $73,734,000. FMR LLC grew its position in DENTSPLY SIRONA by 19.0% in the 4th quarter. FMR LLC now owns 1,218,174 shares of the medical instruments supplier’s stock worth $45,329,000 after purchasing an additional 194,701 shares during the period. Kentucky Retirement Systems bought a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $360,000. Headinvest LLC grew its position in DENTSPLY SIRONA by 84.8% in the 4th quarter. Headinvest LLC now owns 157,682 shares of the medical instruments supplier’s stock worth $5,867,000 after purchasing an additional 72,356 shares during the period. Finally, Abacus Planning Group Inc. bought a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $227,000. 99.18% of the stock is owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: Ex-Dividend
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.